In one paragraphArticle in Nature neuroscience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
9 authors.
Anton J Blatnik *Department of Biological Chemistry and Pharmacology, The Ohio State University Wexner Medical Center, Columbus, OH, USA.
Kaitlyn M KrayDepartment of Biological Chemistry and Pharmacology, The Ohio State University Wexner Medical Center, Columbus, OH, USA.
Summer R BaxleyDepartment of Biological Chemistry and Pharmacology, The Ohio State University Wexner Medical Center, Columbus, OH, USA.
Kristen KentDepartment of Neurology, Neuromuscular Division, The Ohio State University Wexner Medical Center, Columbus, OH, USA.
Rochelle RodrigoDepartment of Neurology, Neuromuscular Division, The Ohio State University Wexner Medical Center, Columbus, OH, USA.
Funding
Therapy for Spinal Muscular AtrophyR01HD060586 · NICHD · OHIO STATE UNIVERSITY · PI BURGHES, ARTHUR H. M. · 2010 to 2021
$3.7MGenetic Suppression of SMN Mutations in Spinal Muscular AtrophyR01NS123736 · NINDS · OHIO STATE UNIVERSITY · PI BURGHES, ARTHUR H. M. · 2021 to 2025
$2.5MThe Role of SMN in Aging Related Weakness: A Novel Therapeutic TargetR56AG055795 · NIA · OHIO STATE UNIVERSITY · PI ARNOLD, WILLIAM DAVID · 2019 to 2019
$504kMaladaptive Remodeling of the Neuromuscular Synapse Following Central Nervous System InjuryF32NS126298 · NINDS · OHIO STATE UNIVERSITY · PI BALCH, MARIA HELEN HARLEY · 2023 to 2025
$187kAAPM&R | Foundation for Physical Medicine and Rehabilitation (Foundation for PM&R) Rehabilitation Research Experience for Medical StudentsU.S. Department of Health & Human Services | NIH | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) R01HD060586U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (NINDS) F32NS126298U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (NINDS) R01NS123736U.S. Department of Health & Human Services | NIH | National Institute on Aging (U.S. National Institute on Aging) R56AG055795
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
What OpenQuestion holds
Textmetadata
Read underepoch 390